COMMUNIQUÉS West-GlobeNewswire

Theolytics to Showcase its Innovative Oncolytic Immunotherapy Strategy – including THEO-260 in Advanced Ovarian Cancer – at Upcoming Investor and Scientific Events
16/09/2026
Oxford, UK, September 16, 2026 – Theolytics, a clinical-stage biotechnology company developing next-generation oncolytic immunotherapies, today announced that members of its senior leadership team will participate in a [...]
Abalos Therapeutics Publishes Two Articles in Viruses Further Validating its AdaptInnate Approach to Treat Solid Tumors
16/09/2026
Preclinical findings further strengthen the scientific foundation for Abalos’ AdaptInnate approach, which leverages systemically administered non-lytic arenaviruses to selectively target solid tumors by triggering body- [...]
Cambium Bio Secures A$10.85 Million to Initiate Pivotal Phase 3 Trial of Elate Ocular®, a Potential First-in-Class Biologic for Dry Eye Disease
16/09/2026
Strategic shareholders commit A$7.1 million at a premium to market, the Company’s fourth consecutive equity raise priced at a premium, alongside A$3.75 million of non-dilutive R&D Tax Incentive pre-financing SYDNEY [...]
Nicox : Les données sur NCX 470 seront présentées lors du Congrès annuel 2026 de l’AAOpt
16/09/2026
Communiqué de presse Nicox : Les données sur NCX 470 seront présentées lors du Congrès annuel 2026 de l’AAOpt 16 septembre 2026 – publication à 7H30 Sophia Antipolis, France Nicox SA (Euronext Growth Paris : [...]
Data on Nicox's NCX 470 to be presented at AAOpt Annual Meeting 2026
16/09/2026
Press Release Data on Nicox's NCX 470 to be presented at AAOpt Annual Meeting 2026 September 16, 2026 – release at 7:30 am Sophia Antipolis, France Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international [...]
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease
16/09/2026
The First and Only Anti-Amyloid Treatment in Japan that Enable At-Home Administration for Alzheimer's Disease, a Progressive Disease TOKYO and CAMBRIDGE, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and [...]
MESSAGE DU CEO DE TME PHARMA
16/09/2026
MESSAGE DU CEO DE TME PHARMA Berlin, Allemagne, le 16 septembre 2026, 8 h 00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de biotechnologie au stade clinique spécialisée dans le développement de [...]
TME PHARMA CEO MESSAGE
16/09/2026
TME PHARMA CEO MESSAGE Berlin, Germany, September 16, 2026, 8.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for [...]
First Patient In - BioPorto Initiates Patient Enrollment as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study.
16/09/2026
September 16, 2026 News Release First Patient In - BioPorto Initiates Patient Enrollment as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study. COPENHAGEN, DENMARK, September 16 , 2026 – BioPorto A/S (“ [...]
Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
16/09/2026
IRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced the pricing of an underwritten public offering of 7,652,175 shares of its common stock at a price to the public of $17 [...]
Greenhouse Treatment Center Strengthens Care Team with Three New Leadership Appointments
16/09/2026
GRAND PRAIRIE, Texas, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Greenhouse Treatment Center, a leading addiction treatment facility in Grand Prairie, Texas, has welcomed three new experienced clinical and medical leaders to [...]
Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical
16/09/2026
CARLSBAD, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” ), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today filed a patent [...]
Keystone Behavioral Health Releases Substance Use Treatment FAQ for York County Patients and Families
16/09/2026
York County provider addresses frequently asked questions about medication-assisted treatment, detox, levels of care and the cost of treatment Rock Hill, SC, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Keystone Behavioral Health [...]
ASHA Congratulates The Pitt for Its Emmy Awards
15/09/2026
TV Medical Drama Spotlights the Importance of Effective Communication Rockville, MD, Sept. 15, 2026 (GLOBE NEWSWIRE) -- The American Speech-Language-Hearing Association (ASHA) congratulates the TV series The Pitt for [...]
NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine
15/09/2026
Abbreviated New Drug Application (ANDA) Amendment related to the drug vial for preservative-free ketamine has been reclassified from a Major Amendment to a Minor Amendment. FDA has revised the Generic Drugs User Fee Act [...]
Acquisition of Own Shares
15/09/2026
Mechelen, Belgium; 15 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform
15/09/2026
-Transaction complements Tempest’s existing CD7-targeted lipid nanoparticle in vivo CAR-T delivery platform, which is planned to enter the clinic later this year -Lead BCMA/GPRC5D dual-targeting in vivo CAR-T candidate [...]
Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
15/09/2026
Lisa Pitt, Pharm.D., M.S.J. appointed Senior Vice President, Regulatory Affairs Shiguang Liu, M.D., Ph.D. appointed Vice President, Clinical Development REDWOOD CITY, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Jasper [...]
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
15/09/2026
HIGH POINT, N.C., Sept. 15, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin , a novel, potential first-in-class oral [...]

Pages